ICH Q1B Photostability & Climatic Chamber Validation: Sensor Mapping, Matrixing & Accelerated Shelf-Life

ICH Q1A(R2) and ICH Q1B govern stability testing of new active pharmaceutical ingredients and drug products across climatic zones I through IVb. Protocols must validate long-term, intermediate, and accelerated conditions, demonstrating product stability throughout the proposed shelf life.

Key testing conditions include: Long-Term (25°C/60% RH or 30°C/65% RH), Accelerated (40°C/75% RH), and Refrigerated (5°C ± 3°C).

Climatic chambers must be qualified with 3D temperature and humidity sensor mapping (USP <1079>). Real-time IoT probes monitor chamber drift: • Mean Kinetic Temperature (MKT): Automated computation of MKT per USP <1150> to evaluate the degradation impact of transient temperature excursions. • Out-of-Tolerance Interlocks: Temperature or humidity excursions exceeding protocol thresholds automatically place stability study samples on electronic hold and initiate a deviation in Novaqis QMS. • Continuous eLog Cleanroom Linking: Stability chambers are tracked as live cleanroom assets within Novaqis eLog™, maintaining verified maintenance and calibration histories.

Novaqis Stability automates sample pull schedules across 0, 1, 2, 3, 6, 9, 12, 18, 24, 36, 48, and 60-month timepoints with configurable grace windows (e.g. ±3 days). Advanced matrixing and bracketing designs reduce analytical workload by testing representative strength and packaging combinations in accordance with ICH Q1D.